Influence of metabolic syndrome on survival of patients with localized renal clear cell carcinoma: A retrospective cohort study in China
-
Published:2023-05
Issue:5
Volume:41
Page:257.e19-257.e26
-
ISSN:1078-1439
-
Container-title:Urologic Oncology: Seminars and Original Investigations
-
language:en
-
Short-container-title:Urologic Oncology: Seminars and Original Investigations
Author:
Liang YingORCID,
Zhang Chengguo,
Luo Jun,
He Yunfeng,
Zhang Yao,
Quan Zhen,
Yang LinORCID
Reference37 articles.
1. Chinese guidelines for the diagnosis and treatment of urological diseases: 2019 edition [M];Na,2019
2. Epidemiology of Renal Cell Carcinoma;Capitanio;Eur Urol,2019
3. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia;Chin Med J (Engl),2022
4. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours;Moch;Eur Urol,2016
5. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma;Leibovich;J Urol.,2010
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献